Detalhe da pesquisa
1.
An individualized causal framework for learning intercellular communication networks that define microenvironments of individual tumors.
PLoS Comput Biol
; 18(12): e1010761, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36548438
2.
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors.
J Transl Med
; 20(1): 331, 2022 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879777
3.
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.
Nat Rev Cancer
; 23(3): 173-188, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456755
4.
PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors' Response and Survival in Advanced Melanoma Patients in Brazil.
Diagnostics (Basel)
; 13(6)2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980349
5.
Tumor cell p38 inhibition to overcome immunotherapy resistance.
Res Sq
; 2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645831
6.
Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15.
Blood
; 116(4): 575-83, 2010 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-20430958
7.
Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands.
Front Immunol
; 13: 837842, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392082
8.
Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.
Clin Dev Immunol
; 2011: 249281, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21969837
9.
Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment.
Cell Rep
; 36(11): 109699, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525351
10.
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083421
11.
Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.
Nat Commun
; 12(1): 7338, 2021 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921143
12.
Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses.
J Exp Med
; 217(7)2020 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369107
13.
Development of flow cytometry assays for measuring cell-membrane enzyme activity on individual cells.
J Cancer
; 11(3): 702-715, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942194
14.
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.
Cancer Immunol Immunother
; 58(1): 121-33, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18488218
15.
Melanoma vaccines: clinical status and immune endpoints.
Melanoma Res
; 29(2): 109-118, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30802228
16.
CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.
Front Immunol
; 10: 14, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761123
17.
Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma.
J Immunother Cancer
; 7(1): 113, 2019 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31014399
18.
A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6.
Clin Cancer Res
; 13(22 Pt 1): 6796-806, 2007 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18006782
19.
ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker.
J Cancer
; 9(14): 2559-2570, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026855
20.
Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.
Front Immunol
; 13: 939789, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35720421